Stock Earnings

Question 1

Quels sont les états financiers clés de Leap Therapeutics Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Leap Therapeutics Inc a un total d'actifs de $49, un bénéfice net loss de $-67

Question 2

Quels sont les ratios financiers clés pour LPTX ?

Accepted Answer

Le ratio de liquidité de Leap Therapeutics Inc est 3.5, la marge nette est 0, les ventes par action sont de $0.

Question 3

Comment les revenus de Leap Therapeutics Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Currently Leap Therapeutics Inc data is not available.

Question 4

Leap Therapeutics Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Leap Therapeutics Inc a un bénéfice net loss de $-67

Question 5

Leap Therapeutics Inc a-t-elle des passifs ?

Accepted Answer

yes, Leap Therapeutics Inc a un passif de 14

Question 6

Combien d'actions en circulation Leap Therapeutics Inc a-t-elle ?

Accepted Answer

Leap Therapeutics Inc a un total d'actions en circulation de 38.33

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	1	1
Revenue Growth (YoY)	--	--	--	-100%	0%	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	10	12	13	11	10	9
Research & Development	51	57	43	44	32	20
Operating Expenses	62	70	57	56	42	30
Other Non Operating Income (Expenses)	0	--	1	2	1	0
Pretax Income	-65	-66	-81	-54	-40	-27
Income Tax Expense	--	0	0	0	0	0
Net Income	-65	-67	-81	-54	-40	-37
Net Income Growth	8%	-17%	50%	35%	8%	12%
Shares Outstanding (Diluted)	41.44	37.55	20.44	11.32	8.58	5.93
Shares Change (YoY)	6%	84%	81%	32%	45%	163%
EPS (Diluted)	-1.58	-1.81	-3.98	-4.82	-4.73	-6.34
EPS Growth	3%	-55%	-17%	2%	-25%	-56.99%
Free Cash Flow	-60	-60	-43	-49	-35	-25
Free Cash Flow Per Share	-1.44	-1.59	-2.1	-4.32	-4.07	-4.21
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	-4,100%	-2,800%
Profit Margin	0%	0%	0%	0%	-4,000%	-3,700%
Free Cash Flow Margin	0%	0%	0%	0%	-3,500%	-2,500%
EBITDA	-62	-70	-57	-56	-41	-28
EBITDA Margin	0%	0%	0%	0%	-4,100%	-2,800%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-62	-70	-57	-56	-41	-28
EBIT Margin	0%	0%	0%	0%	-4,100%	-2,800%
Effective Tax Rate	--	0%	0%	0%	0%	0%

Leap Therapeutics Inc (LPTX) Price